drugset / Trial / NCT03297424
A Study of PLX2853 in Advanced Malignancies.
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to evaluate safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of the investigational drug PLX2853 in subjects with advanced malignancies.
Timeline
- Start
- 2017-09-12
- Primary completion
- 2021-06-07
- Completion
- 2021-06-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PLX2853 | Unknown | — | — |